Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Congenital muscular dystrophy and LGMD panel. 42-gene NGS panel. Genologica Medica Spain | 96 | 42 |
|
Neuronal migration disorder panel. NGS panel of 58 genes. Genologica Medica Spain | 110 | 57 |
|
Lissencephaly panel. NGS panel of 19 genes. Genologica Medica Spain | 33 | 19 |
|
Asper Biogene Asper Biogene LLC Estonia | 59 | 28 |
|
Brain Malformations Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 111 | 56 |
|
Muscular Dystrophy Panel, Congenital CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 47 | 20 |
|
Neuromuscular Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 138 | 62 |
|
Muscular dystrophy-dystroglycanopathy, type A: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 14 | 14 |
|
Muscle Polyneuropathies , Panel Massive Sequencing (NGS) 111 Genes Reference Laboratory Genetics Spain | 159 | 111 |
|
Dystroglycanopathies , Panel Massive Sequencing (NGS) 9 Genes Reference Laboratory Genetics Spain | 22 | 9 |
|
Congenital Muscular Dystrophies, Panel Massive Sequencing (NGS) 12 Genes Reference Laboratory Genetics Spain | 21 | 12 |
|
Walker-Warburg Syndrome , Panel Massive Sequencing 13 Genes Reference Laboratory Genetics Spain | 13 | 13 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 233 | 234 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Developmental Brain Malformations Athena Diagnostics United States | 43 | 40 |
|
Asper Biogene Asper Biogene LLC Estonia | 318 | 252 |
|
Congenital Muscular Dystrophy Advanced Sequencing Evaluation Athena Diagnostics United States | 37 | 23 |
|
Developmental Eye Disease panel Molecular Vision Laboratory United States | 107 | 59 |
|
Muscular dystrophy, dystroglycanopathy Institute of Human Genetics Cologne University Germany | 23 | 13 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.